Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
Feedback from recent FDA interaction indicates that a confirmatory Phase 3 trial evaluating apraglutide in SBS-IF is needed to seek approval Ironwood Pharmaceuticals, Inc., a biotechnology company developing and...